Ad is loading...
DGEAX
Price
$20.62
Change
-$0.19 (-0.91%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DGEAX vs RNWFX

Header iconDGEAX vs RNWFX Comparison
Open Charts DGEAX vs RNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - A
Price$20.62
Change-$0.19 (-0.91%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DGEAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGEAX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEAX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. DGEAX (395M). RNWFX pays higher dividends than DGEAX: RNWFX (1.51) vs DGEAX (0.72). DGEAX was incepted earlier than RNWFX: DGEAX (11 years) vs RNWFX (23 years). DGEAX is a more actively managed with annual turnover of: 44.72 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than DGEAX: RNWFX (250) vs DGEAX (1000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. DGEAX (7.79). DGEAX return over 5 years is better than : 29.70 vs. RNWFX (17.17).
DGEAXRNWFXDGEAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD3.7227.09952%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets395M60.9B1%
Annual Yield % from dividends0.721.5148%
Returns for 1 year7.7911.5467%
Returns for 3 years-26.61-14.55183%
Returns for 5 years29.7017.17173%
Returns for 10 years41.6241.00101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics